Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Feasibility Trial to Determine the Impact of Timing of Surgery and Chemotherapy in Newly Diagnosed Patients With Advanced Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Carcinoma

NCT00075712 is registered in ClinicalTrials.gov with Royal College of Obstetricians and Gynecologists as lead sponsor.

NCT NCT00075712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00075712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Feasibility Trial to Determine the Impact of Timing of Surgery and Chemotherapy in Newly Diagnosed Patients With Advanced Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Carcinoma
Lead sponsor
Royal College of Obstetricians and Gynecologists
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2003
Completion date
Not reported
Enrollment
150 (estimated)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, ovarian cancer, primary peritoneal cavity cancer